Cell-Mediated Immune Responses in Paraneoplastic Neurological Syndromes
Mikołaj Zaborowski
Clinical and Developmental Immunology, 2013
View PDFchevron_right
Current Evidence for the Role of Anti-Neuronal Antibodies in Paraneoplastic Neuronal Disorder
salisu balarabe
Caliphate Medical Journal, 2015
View PDFchevron_right
Cellular Immune Suppression in Paraneoplastic Neurologic Syndromes Targeting Intracellular Antigens
Dana Orange
Archives of Neurology, 2012
View PDFchevron_right
Immunotherapy of Brain Cancers and Neurological Disorders
Prof Alain L Fymat
Journal of Cancer Prevention & Current Research, 2017
View PDFchevron_right
Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat
Christopher Linington
Brain, 2004
View PDFchevron_right
Immunotherapy Can Reject Intracranial Tumor Cells without Damaging the Brain despite Sharing the Target Antigen
Byram Bridle
The Journal of Immunology, 2010
View PDFchevron_right
Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies
Linda Liau
Neurological Research, 2005
View PDFchevron_right
Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain
Linda Liau
Cancer Immunology, Immunotherapy, 2008
View PDFchevron_right
Selection of and evasion from cytotoxic T cell responses in the central nervous system
Stanley Perlman
Advances in Virus Research, 2001
View PDFchevron_right
Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders
Robert Weissert
Frontiers in Immunology, 2017
View PDFchevron_right
Priming in the brain, an immunologically privileged organ, elicits anti-tumor immunity
maria alejandra
International Journal of Cancer, 1998
View PDFchevron_right
Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system
Gary Archer
Proceedings of the National Academy of Sciences, 1996
View PDFchevron_right
Phase I Trial of Vaccination With Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 and Lymphotactin
Donna Rill
Journal of Immunotherapy, 2007
View PDFchevron_right
Naïve CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system
Catherine Toben
Brain, 2008
View PDFchevron_right
Immunogenicity of Human Neuroblastoma
Maria Corrias
Annals of the New York Academy of Sciences, 2004
View PDFchevron_right
Tumor-associated neural differentiation antigens detected on C1300 neuroblastoma cells by hybridoma monoclonal autoantibodies
Rita Businaro
Cellular Immunology, 1982
View PDFchevron_right
CD8+ T Cells Targeting a Single Immunodominant Epitope are Sufficient for Elimination of Established SV40 T Antigen-Induced Brain Tumors
Lawrence Mylin
The Journal of Immunology, 2008
View PDFchevron_right
Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trials
Chiara Cossetti
Experimental Neurology, 2013
View PDFchevron_right
Biologic Principles of Immunotherapy for Malignant Gliomas
Isaac Yang
Neurosurgery Clinics of North America, 2010
View PDFchevron_right
Cells, Molecules and Mechanisms Involved in the Neuro-Immune Interaction
Rodrigo Pacheco
Cell Interaction, 2012
View PDFchevron_right
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen
Roberto Luksch
Cancer research, 2003
View PDFchevron_right
Immunomodulatory Monoclonal Antibodies Combined with Peptide Vaccination Provide Potent Immunotherapy in an Aggressive Murine Neuroblastoma Model
Juliet Gray
Clinical Cancer Research, 2013
View PDFchevron_right
Cellular immunity and immunotherapy of brain tumors
Linda Liau
Frontiers in Bioscience, 2004
View PDFchevron_right
Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
Virgil Schijns
Anti-Cancer Agents in Medicinal Chemistry, 2010
View PDFchevron_right
Bystander killing of neurons by cytotoxic T cells specific for a glial antigen
Heidi Roehrich, Scott Mc Pherson
Glia, 2006
View PDFchevron_right
NK and CD4 Cells Collaborate to Protect against Melanoma Tumor Formation in the Brain
Linda Liau
The Journal of Immunology, 2006
View PDFchevron_right
Immunotherapy for neuroblastoma: Turning promise into reality
Juliet Gray
Pediatric Blood & Cancer, 2009
View PDFchevron_right
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
Valérie Dutoit
Frontiers in oncology, 2016
View PDFchevron_right
Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes
Jan Gratama
2007
View PDFchevron_right
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma
Donna Rill
Blood, 2002
View PDFchevron_right